MLchartDataset catalogue

GDC-0449

Term · Oncology and biomedicine · MLC-T-ONC-003449

A drug used to treat basal cell carcinoma that has spread to other parts of the body, has come back after surgery, or that cannot be treated with surgery or radiation. It is also being studied in the treatment of other types of cancer. GDC-0449 blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of Hedgehog signaling pathway antagonist. Also called Erivedge and vismodegib.

Table 1. Record
IdentifierMLC-T-ONC-003449
FieldOncology and biomedicine
ExpansionsErivedge; vismodegib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-003449",
  "term": "GDC-0449",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat basal cell carcinoma that has spread to other parts of the body, has come back after surgery, or that cannot be treated with surgery or radiation. It is also being studied in the treatment of other types of cancer. GDC-0449 blocks a type of protein involved in tissue growth and repair and may block the growth of cancer cells. It is a type of Hedgehog signaling pathway antagonist. Also called Erivedge and vismodegib.",
  "expansions": [
    "Erivedge",
    "vismodegib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/gdc-0449/"
}

Record 7,854 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.